Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05563051 · ClinicalTrials.gov registry record · NA
Kaneka Endovascular Embolization and Protection
A NA study of Aneurysm Cerebral, sponsored by Kaneka Medical America.
- Active
- Registry status
- NA
- Development phase
- 164
- Enrollment target
- 4
- Study locations
NCT05563051: Active NA study of Aneurysm Cerebral, sponsored by Kaneka Medical America.
NCT05563051 is a NA study of Aneurysm Cerebral that is active but no longer recruiting, run by Kaneka Medical America. The registered enrollment target is 164 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05563051, a NA study of Aneurysm Cerebral, is active but no longer recruiting, sponsored by Kaneka Medical America.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 164 participants
- Enrollment target
- 4
- Study locations
Study Summary
Prospective, multi-center, non-randomized registry / study, up to 164 patients enrolled and followed at 180 days +/- 45 days and again at 365 days +/- 90 days post procedure
Primary Outcome
Proportion of subjects who achieve Adequate Occlusion (Modified Raymond-Roy I or II Classification)
Conditions Studied
Interventions
- DEVICE i-ED COIL
Study Locations (4)
Michigan
- McLaren Health Care - Grand Blanc
New York
- Northwell Health Lenox Hill Hospital - New York
Ohio
- Cleveland Clinic - Cleveland
Oklahoma
- SSM Health St. Anthony's Hospital - Oklahoma City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 164 participants |
| Start Date | 2022-12-13 |
| Est. Completion | 2025-12 |
| Phase | NA |
What the registry record for NCT05563051 still lists
NCT05563051 is an interventional study that assigns participants to a tested intervention. The registered 164 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower).
The record links to 1 condition, with Aneurysm Cerebral appearing as the primary indexed condition, and to 1 intervention - of which i-ED COIL is the first listed.
NCT05563051 reports a single indexed study location in Michigan, New York, Ohio.
Frequently Asked Questions
What is clinical trial NCT05563051 about?
NCT05563051 is a clinical study titled "Kaneka Endovascular Embolization and Protection". Prospective, multi-center, non-randomized registry / study, up to 164 patients enrolled and followed at 180 days +/- 45 days and again at 365 days +/- 90 days post procedure
What is the current status of trial NCT05563051?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 164 participants. The study started on 2022-12-13. Estimated completion is 2025-12.
What conditions does trial NCT05563051 study?
This clinical trial studies the following conditions: Aneurysm Cerebral.
What interventions are being tested in trial NCT05563051?
The interventions under investigation include: i-ED COIL (DEVICE).
Who is sponsoring clinical trial NCT05563051?
This trial is sponsored by Kaneka Medical America, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05563051 being conducted?
This trial has 4 study locations across Michigan, New York, Ohio, Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aneurysm Cerebral
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05563051's enrollment target sits among peer trials
164 626th of 2000 higher than 1,374 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04891289 · 164 participants · Phase 2
Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With Surgery
- NCT04893226 · 164 participants · NA
Time-Restricted Feeding Intervention in Metabolically-Unhealthy Postmenopausal Women
- NCT05270213 · 164 participants · Phase 1
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
- NCT05543681 · 164 participants · Phase 2
Clinical Trial on Agitation in Alzheimer's Dementia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI